In the process of CRISPR adaptation, short pieces of DNA ("spacers") are acquired from foreign elements and integrated into the CRISPR array. It so far remained a mystery how spacers are preferentially acquired from the foreign DNA while the self chromosome is avoided. Here we show that spacer acquisition is replication-dependent, and that DNA breaks formed at stalled replication forks promote spacer acquisition. Chromosomal hotspots of spacer acquisition were confined by Chi sites, which are sequence octamers highly enriched on the bacterial chromosome, suggesting that these sites limit spacer acquisition from self DNA. We further show that the avoidance of "self" is mediated by the RecBCD dsDNA break repair complex. Our results suggest that in E. coli, acquisition of new spacers depends on RecBCD-mediated processing of dsDNA breaks occurring primarily at replication forks, and that the preference for foreign DNA is achieved through the higher density of Chi sites on the self chromosome, in combination with the higher number of forks on the foreign DNA. This model explains the strong preference to acquire spacers from both high copy plasmids and phages.
In cultures overexpressing Cas1 and Cas2 for 16 hours, 36.92% (±1.2) of the sequenced arrays contained a new spacer. Conversely, in cultures where Cas1+2 were not induced, 2.61% (±0.5) of the arrays contained a new spacer after 16 hours of incubation, indicating that the leakage of Cas1+2 transcription (as measured by RNA-seq, Supplementary Table 1) still resulted in spacer acquisition in a significant fraction of the cells (Extended Data Table  1a ). Examining the origin of new spacers showed strong preference for spacer acquisition from the plasmid, with only 22.86% (±0.46) and 1.8% (±0.03) of the spacers derived from the self chromosome in the induced and non-induced cultures, respectively (Extended Data  Table 1b ). Considering the size of the plasmid (4.7kb) and its estimated copy number of 20-40, this represents 100-1000 fold enrichment for acquisition of spacers from the plasmid, as compared to what is expected by the DNA content in the cell. These results also show that lower expression of Cas1+2 leads to higher specificity for exogenous DNA. Therefore, most of the analyses henceforth are based on spacers acquired in conditions in which Cas1+2 are expressed but not overexpressed.
Replication-dependent adaptation
Although only a small minority of spacers was derived from the E. coli chromosome, the extensive number of sequenced spacers allowed us to examine chromosome-scale patterns of spacer acquisition. Remarkably, strong biases in spacer acquisition were observed, defining several protospacer hotspots (Fig. 1a) . As the protospacer adjacent motif (PAM) density on the chromosome scale is largely uniform (Fig. 1b, Extended Data Fig. 2 ), these protospacer hotspots could not be explained by excessive localization of PAM sequences in specific areas of the genome. We further investigated each of the hotspots in search for a mechanism that would explain the observed biases.
Spacer acquisition was more pronounced at areas closer to the chromosomal origin of replication (oriC), with a clear gradient of reduced protospacer density as a function of the distance from oriC (Fig. 1a) . In replicating cells the DNA next to the oriC is replicated first, and hence the culture inevitably contains more copies of the origin-proximal DNA 16 . Indeed, upon sequencing of total genomic DNA extracted from the E. coli BL21-AI culture, we observed a gradient in the DNA content reminiscent of the protospacer gradient (Extended Data Fig. 2 ). Therefore, this oriC-centered spacer acquisition bias can largely be expected based on the average DNA content in the culture and, accordingly, normalizing protospacer density to DNA content eliminated most of the oriC-centered protospacer gradient (Fig. 1b) .
The most striking protospacer hotspot was observed around the chromosomal replication terminus (Ter), in two major peaks showing ~7-20 fold higher protospacer density than the surrounding area (Fig.1b-c) . The Ter macrodomain is the area where the two replication forks coming from opposite directions on the chromosome meet, leading to chromosome decatenation 17 . This chromosomal macrodomain contains unidirectional fork stalling sites called Ter sites (primarily TerA and TerC), which, during replication, stall the early-arriving replication fork until the late fork arrives from the other side 17 . We found that the primary fork-stalling sites TerA and TerC were the exact boundaries of the spacer acquisition hotspots (Fig. 1c) . Moreover, the protospacer hotspots next to Ter sites were asymmetric relative to the fork direction of progression, with strong protospacers enrichment observed upstream to each fork stalling site and a relatively low, background protospacer density downstream to the stalled fork (Fig. 1b-c) . Engineering of a native Ter site into the pheA locus on the bacterial chromosome generated a new localized protospacer hotspot, strongly supporting that hotspots for spacer acquisition directly correlate with replication fork stalling sites (Fig. 1d) .
The correlation between spacer acquisition biases and the replication fork stalling sites may suggest that CRISPR adaptation is promoted by active replication of the protospacercontaining DNA. We conducted a series of experiments to test this hypothesis. First, we used the replication-inhibitor quinolone nalidixic acid on E. coli BL21-AI cells during induction of Cas1+2. As a control, we applied the RNA polymerase inhibitor rifampicin that blocks transcription in E. coli but allows DNA replication (this antibiotic does not interfere with transcription of Cas1+2 by the T7 RNA polymerase). Application of nalidixic acid resulted in an almost complete elimination of spacer acquisition (164x-fold reduction), but only ~2-fold reduction in spacer acquisition rates was observed in the rifampicin-treated cells ( Fig. 2a ; Extended Data Table 1c ), providing support to the hypothesis that spacer acquisition depends on DNA replication.
To further substantiate these observations, we examined the acquisition rates in E. coli K-12 cells carrying the temperature sensitive allele dnaC2 18 . In these cells, initiation of DNA replication is blocked at 39°C but is permitted at 30°C. These cells were transformed with a pBAD-Cas1+2 vector, in which the Cas1+2 operon is directly controlled by an arabinoseinducible promoter. Since these cells encode the full set of Cas genes, the casC gene was also knocked out to avoid CRISPR interference or priming. As a control, we used an isogenic K-12 strain encoding the WT dnaC gene. After overnight growth in the replicationpermissive temperature the two strains showed similar rates of spacer acquisition. However, when the temperature sensitive dnaC2 cells were grown at 39°C, acquisition was almost completely abolished, with less than 0.1% of the sequenced arrays found to be expanded ( Fig. 2b ; Extended Data Table 2a ). These results further strengthen the hypothesis that Cas1+2-mediated spacer acquisition in the E. coli type I-E CRISPR system requires active replication of the protospacer-containing DNA.
We next asked whether spacer acquisition preferences correlate with the position of the replication fork. For this, we transferred a culture of the temperature sensitive dnaC2 cells to 39°C for 70 minutes. Since in this temperature replication re-initiation is inhibited, after 70 minutes there are no more progressing forks in these cells. We then induced Cas1+2 expression for 30 minutes, and transferred the culture to 30°C, resulting in synchronized initiation of replication. At these conditions, it takes the replication forks on average ~60 minutes to complete a full DNA replication cycle in dnaC2 cells 19 . In accordance, we sequenced the newly acquired spacers at 20, 40, 60, 90 and 120 minutes following synchronous replication initiation. Strikingly, the fraction of spacers derived from the Ter region has gradually increased with the progression of the replication cycle, reaching 31% after 60 minutes (compared to only 6.4% at the 20 minutes time point; Fig. 2c ; Extended Data Fig. 3 ; Extended Data Table 2b ). The pattern repeated itself in the second cycle of replication (90 and 120 minutes; Fig 2c) . These results demonstrate temporal correlation between the predicted position of stalled replication forks and the preference to acquire spacers from that position. Combined, the above results support a model where the Cas1+2 complex has preference for acquiring spacers from the area of a stalled replication fork during DNA replication. This model is intriguing, as it largely explains the observed preference for spacer acquisition from high copy number plasmids. During DNA replication in a cell, the chromosome occupies two replication forks traveling from the oriC to the Ter, where their stalling will promote spacer acquisition. At the same replication cycle, each copy of the plasmid will occupy a traveling fork, which will also be stalled during the termination of plasmid replication (in a Ter-independent manner 20 ). Therefore, the vast majority of stalled forks in a replicating cell localize to the multiple plasmid copies, and, if spacer acquisition is promoted by fork-stalling, the probability to acquire spacers from the plasmid is much higher. The model is in line with previous observations in Sulfolobus, showing that spacer acquisition from an infective virus does not occur unless the viral DNA is being replicated 21 .
Involvement of the DNA repair machinery
Another hotspot for spacer acquisition was observed just upstream of the CRISPR I array in the E. coli BL21-AI genome (Fig. 3a) . This CRISPR-associated protospacer hotspot clearly depends on the CRISPR activity, because no hotspot was observed near the E. coli BL21-AI CRISPR II array, which lacks a leader sequence and is hence inactive 7 (Fig. 3a) . Indeed, in E. coli K-12, where both arrays are known to be active, spacer acquisition assays showed a protospacer peak upstream to each of the two arrays (Fig. 3b) . The protospacer peaks at the CRISPR region resembled the peaks seen at the Ter sites, in the sense that they were asymmetric with respect to the replication fork direction, implying that activity at the CRISPR array forms a replication fork stalling site. Presumably the DNA nicking occurring after the leader during insertion of a new spacer 13 , stalls the replication fork thus generating a fork-dependent hotspot for spacer acquisition. Frequent stalling of the fork at the CRISPR would mean that the fork coming from the other direction will often be stalled for a longer time at the respective Ter site, TerC, waiting for the fork coming from the CRISPR direction to arrive (Extended Data Fig. 4 ). This may be one of the factors explaining why the TerC site is a much more pronounced protospacer hotspot than the TerA site (Fig. 1b-c) . Another factor that can contribute to the observed TerC/TerA bias may be that the clockwise replichore in E. coli (oriC to TerA) is longer than the counter clockwise one (oriC to TerC), leading the forks to naturally stall at TerC more often than at TerA.
All of the spacer acquisition hotspots described above were defined by distinct peaks of high protospacer density, with peak widths ranging between 10-50kb (Fig. 3) . On one end, these peaks were bounded by a fork stalling site, but the mechanism defining the boundary at the other end of the peaks was not clear. Strikingly, when searching for sequence motifs that preferentially appear at the other end of the peaks we found that all protospacer peaks were immediately flanked by the 8-mer motif GCTGGTGG, which is the canonical sequence of the Chi site ( Fig. 3a-d) . Chi sites interact with the double-strand break repair helicase/ nuclease complex RecBCD and regulate the repair activity 22 . When a dsDNA break occurs, RecBCD localizes to the exposed end, and then unwinds and degrades the DNA until reaching a Chi site 23 . Upon recognition of the Chi site, RecBCD generally ceases to degrade the DNA, and instead yields a ssDNA that is bound by RecA and invades a homologous duplex DNA, which forms a template for completion of the missing DNA 23 . Chi sites work in an asymmetric manner, meaning that the GCTGGTGG motif will only interact with RecBCD coming from the right-end of the DNA molecule (downstream to the site), whereas the reverse complement of Chi will only interact with RecBCD complexes coming from the left-end of the DNA 22 . RecBCD indiscriminately degrades linear DNA, including phage DNA, and it was therefore suggested that this complex is one of the lines of defense against phages 23 . Since Chi sites occur every ~5kb in the E. coli genome, which is ~14 times more frequent than expected by chance, these sites were suggested as markers of bacterial "self", preventing RecBCD from excessively degrading the chromosome following dsDNA breaks 23 .
Our results show that protospacer hotspots are defined between sites of stalled forks and Chi sites (Fig. 3 ). Stalled replication forks are known to be major hotspots for dsDNA breaks 24, 25 , and it was demonstrated that the vast majority of dsDNA breaks in bacteria occur during DNA replication 23, 26 . These data therefore may imply that Cas1+2 acquires spacers from degradation intermediates of RecBCD activity during the processing of dsDNA breaks that frequently occur at stalled replication forks.
Several lines of evidence support this hypothesis. First, the orientation of the Chi sites at the protospacer peaks was always consistent with the dsDNA break occurring at the fork direction rather than the other side, and the first properly oriented Chi site upstream to the stalled fork was always the site of peak boundary ( Fig. 3a-d) . Second, even outside the strong protospacer hotspots, there was a significant asymmetry in protospacer density upstream and downstream Chi sites (Fig. 4a ). The effect of this asymmetry was seen up to a distance of about 5-10kb from the Chi site, consistent with an average distance of ~5kb between Chi sites in the E. coli genome 22 . Third, inducing a single, site specific dsDNA break in the chromosome using the homing endonuclease I-SceI resulted in a clear protospacer hotspot that peaked at the site of the dsDNA break and was confined by Chi sites in the proper orientations ( Fig. 4b) , directly linking dsDNA breaks to spacer acquisition hotspots. Fourth, co-immunoprecipitation assays suggested that Cas1 interacts with RecB and RecC 27 (although these interactions were not verified using purified proteins), supporting a model where the Cas1+2 complex is directly fed from RecBCD DNA degradation products. And finally, Cas1 was shown to efficiently bind ssDNA, which is amply generated during RecBCD DNA processing activity 23, 27 .
To test whether spacer acquisition indeed depends on the activity of the RecBCD complex, we used E. coli strains in which recB, recC or recD were deleted. Deep-sequencing-based quantification of spacer acquisition rates in these mutants showed reduced acquisition in all of these deletion strains ( Fig. 4e ; Extended Data Table 3a ). Moreover, analysis of chromosomal protospacers in these mutants showed loss of spacer acquisition asymmetry near Chi sites (Fig. 4c) , resulting in broader protospacer hotspots on the self chromosome (Fig. 4d) . In accordance, the fraction of spacers derived from the self chromosome was ~10-fold higher in the recB, recC and recD deletion strains as compared to the WT strain ( 4f; Extended Data Table 3a ). These results show that CRISPR adaptation is partially dependent on the activity of the RecBCD dsDNA break repair complex, and that this activity is also responsible for some of the self/non-self discrimination properties of the CRISPR adaptation process. Consistent with these results, expression of a RecBCD inhibitor protein, the product of gene 5.9 of the T7 bacteriophage 28, showed reduced spacer acquisition as compared to exogenous expression of a control protein (Extended Data Fig. 5 ).
It is noteworthy that in recB and recC deletions, the RecBCD complex is entirely nonfunctional, whereas the recD deletion produces a complex, RecBC, that is fully functional for DNA unwinding but entirely lacks nuclease activity 23 . Our observation that the recD deletion mutant has poor spacer acquisition activity suggests that the nuclease activity of the RecBCD enzyme is important for spacer acquisition and implies that the degradation products generated by RecBCD during DNA processing between dsDNA break and a Chi site may be the source for new spacers.
The involvement of Chi sites, as points where spacer acquisition activity is terminated, provides another axis for the avoidance of self DNA in CRISPR adaptation. Since the pCas plasmid is completely devoid of Chi sites, its DNA will be fully degraded by RecBCD following any dsDNA break, providing plenty of potential substrate for Cas1+2. In contrast, the high density of Chi sites on the bacterial chromosome serves for the relative avoidance of Cas1+2 to acquire spacers from the chromosome, because RecBCD will only degrade the chromosomal DNA until reaching the nearest Chi site ( Fig. 5a-b) . Indeed, the ~10 fold higher acquisition frequency from the self choromosome seen in the recB, recC and recD deletion strains conforms with the natural 14-fold enrichment of Chi sites on the chromosome. To further examine whether Chi sites limit spacer acquisition, we performed spacer acquisition experiments with a plasmid that was engineered to contain a cluster of 4 consecutive Chi sites. As expected, an increased preference for chrmomosomal DNA in spacer acquisition was measured for the Chi-containing plasmid (Fig 4g ; Extended Data Table 3b ; Extended Data Fig. 6 ).
In conclusion, these results converge to a single, unifying model that explains the preference of the CRISPR adaptation machinery to acquire spacers from foreign DNA, as well as the observed biases in spacer acquisition patterns (Fig. 5 ). Under this model, Cas1+2 takes the DNA substrate for spacer acquisition from degradation products of RecBCD activity during the processing of dsDNA breaks. Since the vast majority of dsDNA breaks in the cell occur during DNA replication 26 with stalled replication forks being major hotspots for such breaks 24, 25 , high copy number plasmids are much more prone to spacer acquisition due to the higher number of forks on plasmids (Fig. 5c ). The high density presence of Chi sites on the bacterial chromosome further protects it from extensive spacer acquisition (Fig. 5b) . Moreover, as most phages enter the cell as a linear DNA, and since RecBCD would bind any exposed linear DNA and process it until the nearest Chi site 22 , unprotected phage DNA will be a target for spacer acquisition immediately upon entry to the cell, providing an additional preference for spacer acquisition specifically from phage DNA (Fig. 5d) . If entry to the cell was successful the extensive replication activity of the phage DNA would provide another anchor for spacer acquisition from phage. 
Reagents, strains, and plasmids
Luria-Bertani (LB) medium (10 g/l tryptone, 5 g/l yeast extract, and 5 g/l NaCl) and agar were from Acumedia. Antibiotics and L-arabinose were from Calbiochem. Isopropyl-beta-D-thiogalactopyranoside (IPTG) was from Bio-Lab. Calcium chloride (CaCl 2 ), sodium citrate (Na-citrate), restriction enzymes, T4 Polynucleotide Kinase (PNK) and Phusion high fidelity DNA polymerase were from New England Biolabs. Rapid ligation kit was from Roche. Taq DNA polymerase was from LAMDA biotech. NucleoSpin Gel and PCR Cleanup kit was from Macherey-Nagel (MN). The bacterial strains, plasmids, and oligonucleotides used in this study are listed in Supplementary Table 2 .
Plasmid construction
Plasmids were constructed using standard molecular biology techniques. DNA segments were amplified by PCR. Standard digestion of the PCR products and vector by restriction enzymes was carried out according to the manufacturer's instructions.
pBAD plasmid encoding Cas1 and Cas2 was constructed by amplifying Cas1 and Cas2 from pWUR399 plasmid 29 using oligonucleotides IY86F and IY86R (Supplementary Table 2 ). The amplified DNA and pBAD18 vector were both digested by SacI and SalI and ligated to yield pBAD-Cas1+2. The DNA insert was sequenced to exclude mutations introduced during cloning. pWUR plasmid encoding Cas1 and Cas2 under lac promoter was constructed by amplifying the lac promoter from pCA24N plasmid 29 using oligonucleotides SM18F and OA11R and amplifying the pCas1+2 vector using oligonucleotides IY56F and OA12F (Supplementary Table 2 ). The amplified products were ligated to yield pCas1+2-IPTG and sequenced to exclude mutations introduced during cloning. pWURV2 plasmid was constructed by amplifying the pCas1+2 backbone 29 using oligonucleotides IY81F and IY56R (Supplementary Table 2 ) followed by self-ligation. pCas1+2 plasmids harbouring 4 Chi sites/non Chi sites were constructed by annealing the oligonucleotide MM1F to MM1R or MM2F to MM2R, respectively, and ligating the dsDNA product to NcoI digested pCas1+2. pBAD33-gp5.9 plasmid encoding the T7 gene 5.9 was constructed by amplifying the 5.9 gene from the T7 bacteriophage using oligonucleotides RE45F and IY256R (Supplementary Table 2 ). The amplified DNA and pBAD33 vector were both digested by ScaI and SalI and ligated to yield pBAD33-gp5.9.
Strain construction using recombination-based genetic engineering (recombineering)
BL21-AI recB/C/D deletion mutants were constructed using recombineering method, as described previously 37 . Briefly, an overnight culture of BL21-AI/pSIM6 38 was diluted 75-fold in 250 ml LB + 100 μg/ml ampicillin and aerated at 32 °C. When the OD 600 reached 0.5, the culture was heat-induced for recombination function of the prophage at 42 °C for 15 min in a shaking water bath. The induced culture was immediately cooled on ice slurry and then pelleted at 4600 x g at 0 °C for 10 min. The pellet was washed three times in ice-cold ddH 2 O, then resuspended in 200 μl ice-cold ddH 2 O and kept on ice until electroporation with ~300 ng of a gel-purified PCR product encoding the construct specified in Supplementary Table 2 containing a kanamycin-resistance cassette flanked by 50 bp homologous to the desired insertion site. A 50 μl aliquot of electrocompetent cells was used for each electroporation in a 0.2-cm cuvette at 25 μF, 2.5 kV and 200 Ω. After electroporation, the bacteria were recovered in 1 ml of 2YT (16 g/l bacto-tryptone, 10 g/l yeast extract, 5 g/l NaCl) for 2 h in a 32 °C shaking water bath and inoculated on selection plates containing 25 μg/ml kanamycin. The DNA insertion into the resulting strains was confirmed by DNA sequencing of a PCR product amplifying the region.
Transductions
P1 Transductions were used for replacing araB with a cassette encoding the T7-RNA polymerase linked to tetracycline resistance marker, or thr with dnaC2 allele linked to Tn10 encoding tetracycline resistance marker, or pheA with TerB site linked to Spectinomycin. P1 lysate was prepared as followed: overnight cultures of donor strain BL21-AI (for T7 RNA polymerase) or MG1655dnaC2 (for dnaC2 allele) 31 or JJC1819 (for pheA::TerB-Spec) were diluted 1:100 in 2.5 ml LB + 5 mM CaCl 2 . After 1 h shaking at 37 °C (or 30 °C for MG1655dnaC2), 0 to 100 μl phage P1 was added. Cultures were aerated for 1 to 3 h, until lysis occurred. The obtained P1 lysate was used in transduction where 100 μl fresh overnight recipient culture was mixed with 1.25 μl of 1 M CaCl 2 and 0 to 100 μl P1 phage lysate. After incubation for 30 min at 30 °C without shaking, 100 μl Na-citrate and 500 μl LB were added. Cultures were incubated at 37 °C or 30 °C for 45 or 60 min, respectively, then 3 ml of warm LB supplemented with 0.7% agar was added and the suspension was poured onto a plate containing the appropriate drug. Transductants obtained on antibiotic plates were streaked several times on selection plates and verified by PCR for the presence of the transduced DNA fragment.
Markerless insertion of I-SceI restriction site into the genome
A linear DNA containing the Kan-sacB cassette 39 for kanamycin resistance and sucrose sensitivity was amplified by PCR with oligonucleotides MG53F and MG53R that provided homology to a region downstream to the ydhQ gene. The Kan-sacB cassette was inserted into DY378 strain 40 by recombineering (as described above). Colonies that were found to be resistant to kanamycin and sensitive to sucrose, i.e., containing the Kan-sacB cassette were picked and verified by PCR. The Kan-sacB cassette was transferred by P1 transduction from DY378 to BL21-AI. A second PCR was performed using oligonucleotides MG54F and MG54R that produce a short linear DNA containing the I-SceI restriction site with homology of 50 bp upstream and downstream to the ydhQ stop codon. Recombineering of this DNA fragment to BL21-AI, ydhQ-Kan-sacB resulted in kanamycin sensitive and sucrose resistant colonies that replaced the Kan-sacB cassette with I-SceI restriction site immediately after the ydhQ stop codon. DNA from the resulting strain was sequenceverified for the presence of an intact I-SceI site.
CRISPR array size determination prior to acquisition assay
All strains underwent a preliminary validation step aimed to rule out acquisition prior to induction: E. coli BL21-AI or K-12 harboring pCas1+2 or pBAD-Cas1+2 plasmids, respectively, were spread on LB + 50 μg/ml streptomycin or 100 μg/ml ampicillin + 0.2% (wt/vol) glucose plates and incubated overnight at 37 °C or 30 °C (for K12ΔcasCdnaC2). A single colony was picked from each plate and used as template in a PCR amplifying CRISPR array I for BL21-AI or array II for K-12. Primers MG7R/OA1R and MG7R/ MG34F were used to detect array expansion for BL21-AI and K-12, respectively (Supplementary Table 2 ). Only colonies that did not undergo array expansion were used in the acquisition assays described below.
Standard acquisition assay
A single colony of BL21-AI or BL21-AIΔpheA::terB or BL21-AIΔrecB/C/D strains harboring pCas1+2 plasmid or BL21-AI strain harboring pWURV2 plasmid or K-12ΔcasC T7RNAP strain harboring pBAD-Cas1+2 plasmid or BL21-AI ydhQ-I-SceI site strain harboring pCas1+2-IPTG and pBAD-I-SceI plasmids or BL21-AI strain harboring pChi or pCtrl-Chi plasmids and BL21-AI strain harboring pCas1+2 and pBAD33-gp5.9 plasmids were inoculated in LB medium containing 50 μg/ml streptomycin + 0.2% (wt/vol) glucose for BL21-AI strains carrying a single plasmid or 100 μg/ml ampicillin + 0.2% (wt/vol) glucose for K12 strain or 100 μg/ml ampicillin + 50 μg/ml streptomycin + 0.2% (wt/vol) glucose for BL21-AI ydhQ-I-SceI site/pCas1+2-IPTG/pBAD-I-SceI strain or 200 μg/ml ampicillin + 35 μg/ml chloramphenicol for BL21-AI/ pCas1+2/ pBAD33-gp5.9. Cultures were aerated at 37 °C for 16 h. Each overnight culture was diluted 1:600 in LB medium containing appropriate antibiotics with or without 0.2% (wt/vol) L-arabinose + 0.1 mM IPTG for pCas1+2, pChi and pCtrl-Chi harboring strains or 0.2% (wt/vol) L-arabinose for pBAD-Cas1+2 harboring strains or 0.02 mM IPTG for and 0% L-arabinose for pCas1+2-IPTG and pBAD-I-SceI harboring strain or 0.4% (wt/vol) L-arabinose for pCas1+2 and pBAD33-gp5.9 harboring strain. Cultures were aerated at 37 °C for additional 16 h. DNA from these cultures was used as template (see -DNA preparation for PCR) in PCRs using primers OA1F/IY130R (PCR1) and RE10RD/IY230R (PCR2) for amplifying BL21-AI CRISPR array I or MG116F/MG34F (PCR1, see below) and RE10RD/MG115R (PCR2, see below) for amplifying K-12 array II.
Acquisition assay in the presence of antibiotics
Single colony of BL21-AI/pCas1+2 was inoculated in LB medium containing 50 μg/ml streptomycin + 0.2% (wt/vol) glucose and aerated at 37 °C for 16 h. The overnight cultures were diluted 1:600 in LB medium containing 50 μg/ml streptomycin with or without 0.2% (wt/vol) L-arabinose + 0.1 mM IPTG and aerated at 37 °C. Once cultures reached OD 600 of 0.25, cells were centrifuged in a microcentrifuge for 10 min at 13,000 x g and resuspended in LB medium containing 50 μg/ml streptomycin or 50 μg/ml nalidixic acid or 100 μg/ml rifampicin with or without 0.2% (wt/vol) L-arabinose + 0.1 mM IPTG. Cultures were aerated for 16 h at 37 °C, lysed and served as template for PCR1 using primers OA1F/ IY130R (PCR1) and RE10RD/IY230R (PCR2) for amplifying BL21-AI CRISPR array I.
Acquisition assay in replication-deficient strains
Single colony of K-12ΔcasC (control) or K-12ΔcasCdnaC2 harboring pBAD-Cas1+2 was inoculated in LB medium containing 100 μg/ml ampicillin + 0.2% (wt/vol) glucose and aerated at 30 °C, for 16 h. The overnight cultures were diluted 1:600 in LB medium containing 100 μg/ml ampicillin + 0.2% (wt/vol) L-arabinose and aerated at 30 °C or 39 °C for another 16 h. Cultures were then lysed and used as template in PCRs using primers MG116F/MG34F (PCR1) and RE10RD/MG115R (PCR2) for amplifying K-12 array.
Synchronized acquisition assay
Single colony of K-12ΔcasC (control) or K-12ΔcasCdnaC2 harboring pBAD-Cas1+2 was inoculated in LB medium containing 100 μg/ml ampicillin + 0.2% (wt/vol) glucose and aerated at 30 °C, for 16 h. The overnight cultures were diluted 1:600 in LB medium containing 100 μg/ml ampicillin + 0.2% (wt/vol) glucose and aerated at 30 °C until OD 600 reached 0.25. Cultures were then split into six tubes and transferred to non-permissive temperature − 39 °C. After 70 min, induction of Cas1+2 was performed: cells were centrifuged in a standard centrifuge (4,600 x g, 10 min), resuspended in LB medium containing 100 μg/ml ampicillin + 0.2% (wt/vol) L-arabinose and aerated for additional 30 min at 39 °C. Replication was then initiated by aerating the split cultures at 30 °C for -0, 20, 40, 60, 90, 120 min. For replication arrest, cells were lysed and used as template in PCRs using primers MG116F/MG34F (PCR1) and RE10RD/MG115R (PCR2) for amplifying K-12 array.
DNA preparation for PCR
DNA was prepared from all cultures that underwent acquisition assays. 1 ml of each culture was centrifuged in a microcentrifuge for 1 min at 13,000 x g and re-suspended in 100 μl LB medium. The concentrated culture underwent fast freeze in liquid nitrogen, boiled at 95 °C for 10 min and placed on ice for 5 min. The lysate was then centrifuged in a microcentrifuge for 2 min at 13,000 x g, the supernatant was transferred to a new tube and served as template for PCR1 (see Preparation of DNA samples for deep sequencing).
Cultures preparation for RNA-seq
Single colony of E. coli BL21-AI strain harboring pCas1+2 plasmid was inoculated in LB medium containing 50 μg/ml streptomycin + 0.2% (wt/vol) glucose and aerated at 37 °C for 16 h. Each overnight culture was diluted 1:600 in LB medium containing appropriated antibiotics with or without: 0.2% (wt/vol) L-arabinose + 0.1 mM IPTG. Following overnight growth cultures 15 ml from each culture was centrifuged in a standard centrifuge (4,600 x g, 10 min), the supernatant was discarded and the pellet underwent fast freeze in liquid nitrogen. Cell pellets were then thawed and incubated at 37°C with 300 μl 2 mg/ml lysozyme (Sigma-Aldrich cat# L6876-1G) in Tris 10mM EDTA 1mM pH 8.0, and total nucleotides were extracted using the Tri-Reagent® protocol, according to manufacturers instructions (Molecular Research Center, Inc. cat# TR118). TURBO DNA-free ™ Kit was used to eliminate DNA from the sample, according to the manufacturer instructions (Life technologies -Ambion cat# AM1907). Enrichment for mRNA was accomplished by using the Ribo-Zero ™ rRNA Removal Kits (Illumina-Epicentre cat#MRZB12424). The enriched mRNA sample was then further purified using Agencourt® AMPure® XP magnetic beads (Beckman Coulter cat# A63881). Purified bacterial mRNA was then used as the starting material for the preparation of cDNA libraries for next-generation sequencing using NEBNext® Ultra ™ Directional RNA Library Prep Kit for Illumina® (NEB cat# E7420S).
The NEBNext® multiplex oligos for Illumina® Index primer set1 (NEB cat#E7335S) was used as the adapters for the library.
Total DNA purification
Overnight cultures of E. coli BL21-AI or K-12ΔcasC T7RNAP harbouring pCas1+2 or pBAD-Cas1+2 plasmid, respectively, were diluted 1:600 and aerated for 16h at 37 °C in LB medium containing 50 μg/ml streptomycin or 100 ampicillin μg/ml + 0.2% (wt/vol) glucose. These overnight cultures were then diluted 1:600 in LB medium containing 50 μg/ml streptomycin or 100 ampicillin μg/ml with 0.2% (wt/vol) L-arabinose + 0.1 mM IPTG or without inducers and aerated at 37 °C. Once cultures reached OD 600 of 0.5-0.6 3 ml were removed and used for total DNA purification using the Macherey-Nagel NucleoSpin Tissue kit. Total DNA samples were used for deep sequencing (MiSeq).
Preparation of spacer PCR products for deep sequencing
DNA from bacterial cultures that underwent various acquisition assays was amplified in two consecutive PCRs termed PCR1 and PCR2. In PCR1, The reaction contained 20 μl of Taq 2× Master Mix master mix, 1 μl of 10 μM forward and reverse primers (see Supplementary  Table 2 ), 4 μL of bacterial lysate, and 14 μL of double-distilled water. The PCR started with 3 min at 95 °C followed by 35 cycles of 20 s at 95 °C, 20 s at 55 °C, and 20 s at 72 °C. The final extension step at 72 °C was carried out for 5 min. Half of the PCR1 content (20 μl) was purified using the DNA clean-up kit and were used for standard library prep procedures followed by deep sequenced (MiSeq), while the other half (20 μl) was loaded on a 2% (wt/ vol) agarose gel and electrophoresed for 60 min at 120 V. Following gel separation, the expanded band was excised from the gel and purified using the DNA clean-up kit. 1 ng from the extracted band served as a template for the PCR2 reaction aimed to amplify the expanded CRISPR array products. PCR2 contained 10 μl of Taq 2× Master Mix master mix, 0.5 μl of 10 μM forward and reverse primers (Supplementary Table 2 ), 1 ng of the gelextracted DNA from PCR1, and double-distilled water up to 20 μl. PCR2 program was identical to that of PCR1. The entire PCR2 content was loaded on a 2% (wt/vol) agarose gel, electrophoresed, excised and purified from the gel using the same conditions as in PCR1.
Detection of protospacer identity and acquisition level
The PCR products described above were used for preparation of Illumina sequencing libraries and were sequenced using HiSeq or MiSeq machines according to manufacturer instructions. Several samples were multiplexed together in the same sequencing run. Demultiplexing was done to the different samples based on the different Illumina barcodes and based on 3 bp barcode that was part of the original PCR primer.
Reads were mapped against the E. coli genome and pCAS plasmid using blastn (with parameters: −e 0.0001 −F F). For strain K-12 the Refseq accession NC_000913.2 was used and for strain BL21-AI (for which genomic sequence is unavailable) the E. coli BL21-Gold(DE3)pLysS AG was used (Refseq accession NC_012947.1).
New spacer insertions were called based on sequence alignments of the resulting reads. For round 1 of the PCR (Extended Data Fig. 1 ) alignments supporting non-acquisition events Levy et al.
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were also recorded to quantify acquisition level. If the sequence read was fully mapped to the parental CRISPR locus in the leader-proximal side, a non-acquisition event was inferred. New acquisition events were inferred if the read alignment begun by a substring that was mapped to the CRISPR locus ('pre-acquisition' mapping) followed by a spacer-length substring that mapped elsewhere on the genome or the plasmid. Uninformative alignments, resulting from sequencing of the leader-distal side of the PCR amplicon were discarded. Spacer acquisition level for a sample was defined as the number of reads supporting acquisition events divided by the number of reads either supporting or rejecting spacer acquisition.
For round 2 of the PCR (enriching for expanded arrays only, Extended Data Fig. 1 ) we used only unambiguously mapped protospacers (e.g., spacers mapped to repetitive rRNA genes were discarded). In case that a spacer was mapped equally well both to the genome and the pCAS plasmid, only the plasmid protospacer position was used.
For the plots of protospacer distribution and hotspots (except for the plot in Extended Data Fig. 3 ), protospacer positions were recorded only once (meaning that if there were multiple spacers hitting the exact same position, the position was considered only once). This procedure was done in order to avoid biases stemming from PCR amplification of the CRISPR array, as well as local biases stemming from differential PAM preferences 12 .
Data analysis was done using Perl and R scripts. Data visualization and statistical analysis was done using Excel and R, including the R circular package (http://cran.rproject.org/web/ packages/circular/circular.pdf) for DNA from cultures of either E. coli K-12 (left) or E. coli BL21-AI (right) strains expressing Cas1+2 from two different plasmids were used as templates for PCR. Round 1 was used to determine the frequency of spacer acquisition by comparing occurrences of expanded arrays to WT arrays. Round 2 amplified only the expanded arrays and, followed by deep sequencing, was used to determine the sequence, location, and source of newly acquired spacers.
Adaptation experiments with E. coli BL21-AI cells
Following overnight growth with or without induction of Cas1+2 cloned on pWUR plasmid, the CRISPR array was amplified and sequenced to determine the fraction of arrays that acquired a new spacer. Results with BL21-AI with an empty pWUR vector (without Cas1+2) are presented as a control. 
Identity of acquired spacers in E. coli BL21-AI cells
Following overnight growth with or without induction of Cas1+2, gel-separated expanded arrays were amplified and sequenced, to study the identity of newly acquired spacers in high resolution. 
Effect of antibiotics on adaptation levels
The Cas1+2 operon was induced in E. coli BL21-AI cells using 0.2% L-arabinose and 0.1mM IPTG overnight, in the presence of either nalidixic acid (50 μg/ml) or rifampicin (100 μg/ml). Following overnight induction, the CRISPR array was amplified and sequenced. Time course adaptation experiments with synchronously replicating dnaC2 temperature sensitive cells Temperature sensitive K-12ΔcasCdnaC2 culture was transferred to 39°C for 70 minutes. Cas1+2 expression was then induced for 30 minutes using 0.2% L-arabinose and 0.1mM IPTG, and the culture was transferred to 30°C with continuous induction of Cas1+2. Culture was sampled at successive time points following synchronous replication initiation, and the CRISPR array was amplified and sequenced to determine the fraction of cells that acquired a new spacer. In addition, gel-separated expanded arrays were amplified and sequenced, to study the localization of spacers derived from the chromosome. Adaptation experiments with E. coli BL21-AI ΔrecB, ΔrecC, ΔrecD and ydhQ::I-SceI cells
Sequencing of the CRISPR array PCR product
Following overnight growth without induction of Cas1+2, the CRISPR array was amplified and sequenced to determine the fraction of cells that acquired a new spacer. In addition, gel-separated expanded arrays were amplified and sequenced, to study the identity of newly acquired spacers in high resolution. 

Adaptation experiments with E. coli BL21-AI pCas1+2-Chi
Following overnight growth without induction of Cas1+2 from the pChi plasmid (which contains a cluster of 4 counter clockwise Chi sites on a 50bp cassette inserted at position 1300 of the pCas plasmid) gel-separated expanded arrays were amplified and sequenced, to differentiate between spacers acquired from self and plasmid DNA. As a control a similar plasmid with a 50bp Chi-less insertion at the same position in the pCas plasmid was used. by a Chi site (compare to the same hotspot in the WT strain, Fig. 3A) . (E) Adaption levels in WT BL21-AI and BL21-AIΔrecB, ΔrecC or ΔrecD strains following overnight growth without arabinose induction of Cas1+2. (F) Percent new spacers derived from the self chromosome in the experiment described in Panel E. (G) Percent new spacers derived from the self chromosome in the presence of a plasmid that contains a cluster of 4 Chi sites (pChi) as compared to an identical plasmid that lacks Chi sites (pCtrl-Chi). For panels E-G, average and error margins for two biological replicates are shown.
